Vaccines & Disease · COVID-19

SARS-CoV-2 Virus & COVID-19 Quick Facts

Published November 8, 2021 · 4 min read
01

SARS-CoV-2 & COVID-19 Quick Facts

  • SARS-CoV-2 is one strain (type) of coronavirus that is part of a large family of enveloped RNA viruses that can infect mammals and birds.1 Coronaviruses are named for their crown-like spiked surfaces and most often cause mild respiratory symptoms like the common cold in humans.2
  • A few coronavirus strains can cause very severe respiratory disease with significant mortality, such as Severe Acute Respiratory Syndrome (SARS) that emerged in China in 2002-20033 and Middle Eastern Respiratory Syndrome (MERS) that was first reported in Saudi Arabia in 2012.4 SARS-CoV-2, which was identified in China in late 20195 and declared a global pandemic by the World Health Organization (WHO) in March 2020,67 has a much lower mortality rate than SARS or MERS.8
  • People with SARS-CoV-2 infections can be asymptomatic9 or exhibit a constellation of mild or severe illness symptoms known as COVID-19, which include fever; chills; cough; shortness of breath/difficulty breathing, fatigue; muscle, joint or body aches; rash; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting, and diarrhea.10 Multiple studies have found that individuals who recover from COVID-19 illness have long-term immunity and rarely suffer a second COVID-19 infection.11121314
  • Complications of COVID-19 disease include pneumonia; acute respiratory distress syndrome (ARDS); acute kidney, liver, and heart failure or damage; septic shock; disseminated intravascular coagulation (DIC); rhabdomyolysis (muscle breakdown); chronic fatigue syndrome; blood clots and death.15 Serious complications of COVID-19 occur when an infection triggers the immune system to flood the bloodstream with inflammatory proteins (cytokines) that can damage organs and kill tissue.16 In some young children and adolescents, SARS-CoV-2 infections may trigger multisystem inflammatory syndrome (MIS-C).1718
  • In 2020 about 94 percent of COVID-19 related-deaths occurred in persons over age 65 and individuals with underlying poor health conditions, with only about 6 percent involving healthy persons or in persons under the age of 65.19 Those considered at highest risk for severe COVID-19 disease are the immunocompromised; pregnant women; individuals with chronic heart, lung or kidney disease; the obese; type 2 diabetics; and individuals with cancer, Down’s syndrome, sickle cell disease and thalassemia. Other conditions that may be at increased risk for severe COVID-19 disease include asthma, high blood pressure, dementia and neurologic conditions, liver disease, cystic fibrosis, and type 1 diabetes.20
02

COVID-19 Vaccine Quick Facts

  • On Mar. 10, 2020, the U.S. Secretary of the Department of Health and Human Services (DHHS) declared the COVID-19 pandemic a public health emergency and invoked the 2005 Public Readiness and Emergency Preparedness (PREP) Act. The public health emergency ended in the U.S. on May 11, 2023. However, COVID-19 vaccines remain a public health emergency “countermeasures” and continue to fall under the PREP Act, which shields manufacturers and vaccine providers from liability. The Countermeasures Injury Compensation Program (CICP) awards compensation to those injured by countermeasure vaccines.21222324
  • There are two COVID-19 vaccines for use in the U.S. Comirnaty mRNA COVID-19 vaccine,25 developed and manufactured by Pfizer-BioNTech, and Spikevax mRNA COVID-19 vaccine,26 developed and manufactured by Moderna. Both vaccines are monovalent mRNA COVID-19 vaccines containing the SARS-CoV-2 Omicron variant XBB.1.5. and are approved for use in individuals age 12 years and older.
  • Additional COVID-19 Vaccines available for use through Emergency Use Authorization (EUA) by the FDA. These vaccines include two mRNA COVID-19 vaccines produced by Pfizer-BioNTech for use in infants and children aged 6 months through 4 years and for children five through 11 years of age27 and one mRNA COVID-19 vaccine produced by Moderna for use in infants aged 6 months through 11 years.28 There is one protein subunit vaccine, Novavax, authorized for use in individuals 12 years of age and older.29According to the FDA, “Under an EUA, FDA may allow the use of unapproved medical products, or unapproved uses of approved medical products in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when certain statutory criteria have been met, including that there are no adequate, approved, and available alternatives.”30 An EUA status may be given for licensed, experimental, approved or conditionally approved vaccines and require that vaccine recipients must “have the option to accept or refuse the vaccine.”31
  • Serious adverse events associated with COVID-19 vaccines include myocarditis and pericarditis, Guillain-Barré syndrome (GBS), ischemic stroke, TTS,32 shingles33, Graves’ Disease (an autoimmune disorder affecting the thyroid),34 blood clots,35363738 acute myocardial events,39 kidney disorders,40 erythema multiforme (allergic skin reaction characterized by red, raised, symmetrical areas over the entire body),41 Central Nervous System (CNS) Demyelination, including multiple sclerosis (MS),42 Multisystem Inflammatory Syndrome (MIS),43 tinnitus,4445 prion disease (a rare, fatal, transmissible spongiform encephalopathy),46 organ transplant rejection,4748 anaphylaxis,4950 and death.51525354555657
  • Health officials have warned that, while there is evidence that COVID-19 vaccines can prevent symptomatic COVID-19 disease, there is a lack of evidence that the vaccines are effective in preventing infection and transmission of SARS-CoV-2.585960616263 Pfizer company officials have acknowledged that prior to EUA status, clinical trials were not conducted to determine whether the vaccine would stop transmission of the virus.64
  • As of the January 2, 2026 release of data from CDC, there have been 1,673,223 reports of adverse events following vaccination with COVID-19 vaccines submitted to the federal vaccine adverse event reporting system (VAERS), which noted 324,369 serious adverse events; 41,551 life-threatening events; 222,078 hospitalizations; and 38,983 deaths. Reported adverse events have included pain at the injection site; fatigue; anaphylaxis; headache; muscle and joint pain; fever; chills;65 swollen lymph nodes; nausea and vomiting;66 immune thrombocytopenia purpura (ITP) (low blood platelets);6768 Bell’s Palsy;69 tinnitus;70 cardiac arrest; neurological dysfunction; rheumatoid arthritis; blood clots; heart, kidney and liver failure;71 anaphylaxis; myocarditis and pericarditis;72 Guillain-Barré syndrome (GBS)73 and death.747576 Click for most recent CDC data release.
Food & Drug Administration (FDA)
National Institutes of Health (NIH)

IMPORTANT NOTE: NVIC encourages you to become fully informed about covid-19 and the covid-19 vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1Mandal A. The role of micro-RNA in SARS-CoV-2 infection and COVID-19. News-Medical Nov. 24, 2020.
  2. 2US Centers for Disease Control and Prevention. Common Human Coronaviruses. Feb. 13, 2020.
  3. 3US Centers for Disease Control and Prevention. Frequently Asked Questions about SARS. May 3, 2005.
  4. 4US Centers for Disease Control and Prevention. About MERS. Aug. 2, 2019.
  5. 5Wu YC, Chen CS, Chan YS. The outbreak of COVID-19: An overview. J Chin Med Assoc March 2020; 83(3): 217-220.
  6. 6Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed March 2020; 91(1): 157-160.
  7. 7Fisher BL. Coronavirus (COVID-19) Pandemic: NVIC Special Report. National Vaccine Information Center (NVIC) June 2020.
  8. 8Hewings-Maven Y. How do SARS and MERS compare with COVID-19?. Medical News Today Apr. 10, 2020.
  9. 9Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. ELife May 2020.
  10. 10US Centers for Disease Control and Prevention. Symptoms of COVID-19. Oct. 26, 2022.
  11. 11National Institutes of Health (NIH). Lasting immunity found after recovery from COVID-19. NIH Research Matters Jan. 26, 2021.
  12. 12Washington University School of Medicine in St. Good news: Mild COVID-19 induces lasting antibody protection. May 24, 2021.
  13. 13Shrestha NK, Burke PC, Nowacki AS. Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19. Clin Infect Dis. Aug 24, 2022.
  14. 14Alexander PE. 160 plus Research Studies Affirm Naturally Acquired Immunity to Covid-19: Documented, Linked, and Quoted. Brownstone Institute Oct. 17, 2021.
  15. 15WebMD. Complications Coronavirus Can Cause. Aug. 9, 2021.
  16. 16Song P, Li W, Xie J et al. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020; 509: 280-287.
  17. 17Mayo Clinic. Multi-system inflammatory syndrome in children (MIS-C) and COVID-19. July 22, 2023.
  18. 18Bhaskar S, Sinha A, Banach M, et al. Cytokine Storm in COVID-19: Immunopathological Mechanisms, Clinical Considerations and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol 2020.
  19. 19Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR 2020; 69(15): 458-464.
  20. 20US Centers for Disease Control and Prevention. People with Certain Medical Conditions. May 11, 2023.
  21. 21Congressional Research Service. The PREP Act and COVID-19: Limiting Liability for Medical Countermeasures. Apr. 13, 2022.
  22. 22Garde D. 6 burning questions Congress could push Covid-19 vaccine makers to answer today. Stat News July 20, 2020.
  23. 23Fisher BL. 2005 PREP Act and 1986 Act Shield Vaccine Manufacturers from Liability. The Vaccine Reaction Aug. 10, 2020.
  24. 24US Department of Health & Human Services. HHS Secretary Xavier Becerra Statement on End of the COVID-19 Public Health Emergency. May 11, 2023.
  25. 25BioNTech Manufacturing GmbH. Comirnaty. U.S. Food and Drug Administration Sept. 11, 2023.
  26. 26ModernaTx, Inc. Spikevax. U.S. Food and Drug Administration Sept. 11, 2023.
  27. 27US Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Healthcare Provider. Sept. 11, 2023.
  28. 28US Food and Drug Administration. Moderna COVID-19 Vaccine Fact Sheet for Healthcare Provider. Sept. 11, 2023.
  29. 29US Food and Drug Administration. Novavax COVID-19 Vaccine Fact Sheet for Healthcare Provider Administering Vaccine. Mar. 28, 2023.
  30. 30US Food and Drug Administration. Emergency Use Authorization for Vaccines Explained. Nov. 20, 2020.
  31. 31Office of the Law Revision Counsel – United States Code. 21 U.S. Code 360bbb-3- Authorization of medical products for the use in emergencies. Sept. 15, 2023.
  32. 32US Centers for Disease Control and Prevention. Selected Adverse Events Reported after COVID-19 Vaccination. Sept. 12, 2023.
  33. 33Furer V, Zisman D, Kibari A, et al. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford) Apr. 12, 2021.
  34. 34Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP et al. Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Thyroid 2021; 31(9):1436-1439.
  35. 35Lee EJ, Cines DB, Gernsheimer T et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol May 1, 2021; 96(5):534-537.
  36. 36European Medicines Agency. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021. May 2021.
  37. 37Stieber Z. Authorities Probe Rare Blood Disorder Among Some COVID-19 Vaccine Recipients. The Epoch Times Feb. 11, 2021.
  38. 38Stieber Z. Pfizer’s COVID-19 Vaccine Linked to Blood Clotting: FDA. The Epoch Times Dec. 17, 2022.
  39. 39Sun CLF Jaffe E. Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Sci Rep Apr. 28, 2022.
  40. 40TVR Staff. Do mRNA COVID Biologics Cause Skin Allergy and Kidney Disorders?. The Vaccine Reaction Aug. 15, 2021.
  41. 41TVR Staff. Do mRNA COVID Biologics Cause Skin Allergy and Kidney Disorders?. The Vaccine Reaction Aug. 15, 2021.
  42. 42Khayat-Khoei M, Bhattacharyya S, Katz J. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. Sept. 4, 2021.
  43. 43European Medicines Agency. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021. Sept. 3, 2021.
  44. 44Blasius M. Unheard Concerns: Thousands blame COVID-19 vaccine for hearing problems. ABC 15 Arizona Sept. 17, 2021.
  45. 45Parrino D, Frosolini A, Gallo C et al. Tinnitus following COVID-19 vaccination: report of three cases. Int J Audiol Jun 2022; 61(6):526-529.
  46. 46National Institute of Allergy and Infectious Disease. Prion Disease. Oct. 21, 2019.
  47. 47Fujio K. Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review. J Clin Med Aug. 2, 2022.
  48. 48Alhumaid S, Rabaan AA, Dhama K et al. Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis. Vaccines (Basel) Aug 10, 2022.
  49. 49US Centers for Disease Control and Prevention. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020. MMWR Jan. 15, 2021; 70(2):46–51.
  50. 50Shimabukuro T. COVID-19 vaccine safety update Advisory Committee on Immunization Practices (ACIP). U.S. Centers for Disease Control and Prevention Jan. 27, 2021.
  51. 51Attkisson S. Deaths of Elderly Who Recovered From COVID-19, but Died After Vaccine, Raise Questions. The Epoch Times Feb. 10, 2021.
  52. 52Cáceres M. Hammerin’ Hank’s COVID-19 Vaccination: A “Double-Edged Sword”?. The Vaccine Reaction Jan. 31, 2021.
  53. 53Torjesen I. Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination. BMJ 2021.
  54. 54TVR Staff. Two Elderly Men Die Hours After Getting COVID-19 Vaccines in Israel. The Vaccine Reaction Jan. 1, 2021.
  55. 55Penza N. Portuguese health worker, 41, dies two days after getting the Pfizer covid vaccine as her father says he 'wants answers'. DailyMail.com Jan. 11, 2021.
  56. 56TVR Staff. Four Persons Die Days After COVID-19 Vaccinations in Portugal, Switzerland and Norway. The Vaccine Reaction Jan. 11, 2021.
  57. 57Thomas SJ, Moreira ED Jr, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. – Supplementary Appendix. N Engl J Med 2021; 385:1761-73.
  58. 58Sky News Australia. WHO doesn’t have evidence vaccines prevent people transmitting virus to others. Dec. 29, 2020.
  59. 59Kim S. Dr. Fauci on Mandatory COVID Vaccines: ‘Everything Will Be on the Table. Newsweek Jan. 1, 2021.
  60. 60Fisher BL. WHO and Fauci Warn COVID-19 Vaccines May not Prevent Infection and Disease Transmission. The Vaccine Reaction Jan. 4, 2020.
  61. 61Caceres B. COVID Vaccines Not Proven to Prevent SARS-CoV-2 Infection or Transmission. The Vaccine Reaction Aug. 9, 2021.
  62. 62Johnson & Johnson. Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA for Emergency Use – First Single Shot Vaccine in Fight Against Global Pandemic. Feb. 27, 2021.
  63. 63Stokel-Walker C. What do we know about covid vaccines and preventing transmission?. BMJ Feb 4, 2022.
  64. 64Phillips J. Pfizer Exec Concedes COVID-19 Vaccine Was Not Tested on Preventing Transmission Before Release. The Epoch Times Oct. 13, 2022.
  65. 65US Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Healthcare Provider. Sept. 11, 2023.
  66. 66US Food and Drug Administration. Moderna COVID-19 Vaccine Fact Sheet for Healthcare Provider. Sept. 11, 2023.
  67. 67Fisher BL. Miami Obstetrician Develops Bleeding Disorder, Dies After Receiving COVID-19 Vaccine. The Vaccine Reaction Jan. 11, 2021.
  68. 68Stieber Z. Authorities Probe Rare Blood Disorder Among Some COVID-19 Vaccine Recipients. The Epoch Times Feb. 11, 2021.
  69. 69US Food and Drug Administration. Briefing Document- Pfizer-BioNTech COVID-19 Vaccine.
  70. 70Parrino D, Frosolini A, Gallo C et al. Tinnitus following COVID-19 vaccination: report of three cases. Int J Audiol. June 2022; 61(6):526-529.
  71. 71Fisher BL. Healthy Mom, 39, in Utah Dies of Organ Failure Four Days After Moderna COVID Vaccination. The Vaccine Reaction Mar. 15, 2021.
  72. 72US Centers for Disease Control and Prevention. Selected Adverse Events Reported After COVID-19 Vaccination. Sept. 12, 2023.
  73. 73George J. FDA To Warn About Post-COVID Vax Guillain-Barré Syndrome — Cases seen in people who received Johnson & Johnson's vaccine. Medpage Today July 12, 2021.
  74. 74Attkisson S. Deaths of Elderly Who Recovered From COVID-19, but Died After Vaccine, Raise Questions. The Epoch Times Feb. 10, 2021.
  75. 75Caceres M. Why Is Death After COVID-19 Vaccination Always Assumed to Be Coincidental?. The Vaccine Reaction Mar. 1, 2021.
  76. 76US Centers for Disease Control and Prevention. Selected Adverse Events Reported After COVID-19 Vaccination. Sept. 12, 2023.
Select disease / vaccine